OomenAG, SteinhäuserKG, BleekerEA, et al.Risk assessment frameworks for nanomaterials: Scope, link to regulations, applicability, and outline for future directions in view of needed increase in efficiency. NanoImpact, 2018; 9:1–13.
2.
DrewNM, KuempelED, PeiY, et al.A quantitative framework to group nanoscale and microscale particles by hazard potency to derive occupational exposure limits: Proof of concept evaluation. Regul Toxicol Pharmacol, 2017:89:253–267.
3.
NelA, XiaT, MengH, et al.Nanomaterial toxicity testing in the 21st century: Use of a predictive toxicological approach and high-throughput screening. Acc Chem Res, 2013; 46:607–621.
4.
AccomassoL, CristalliniC, GiachinoC. Risk assessment and risk minimization in manomedicine: A need for predictive, alternative, and 3Rs strategies. Front Pharmacol, 2018; 9:228.
5.
FadeelB, FarcalL, HardyB, et al.Advanced tools for the safety assessment of nanomaterials. Nat Nanotechnol, 2018; 13:537–543.
6.
MattssonMO, SimkoM. The changing face of nanomaterials: Risk assessment challenges along the value chain. Regul Toxicol Pharmacol, 2017; 84:105–115.
7.
OECD. Alternative testing strategies in risk assessment of manufactured nanomaterials: Current state of knowledge and research needs to advance their use. No. 80, Series of the Safety of Manufactured Nanomaterials, ENV/JM/MONO (2016). 63: 2017; p. 36.
8.
KermanizadehA, GosensI, MacCalmanL, et al.A multilaboratory toxicological assessment of a panel of 10 engineered nanomaterials to human health—ENPRA Project—The highlights, limitations, and current and future challenges. J Toxicol Environ Health B Crit Rev, 2016; 19:1–28.
9.
SchugTT, NadadurSS, JohnsonAF, et al.Consortium—A team science approach to assess engineered nanomaterials: reliable assays and methods. Environ Health Perspect, 2013; 121:A176–177.
WangR, SongB, WuJ, et al.Potential adverse effects of nanoparticles on the reproductive system. Int J Nanomed, 2018; 13:8487–8506.
12.
JohnstonH, PojanaG, ZuinS, et al.Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: Potential solutions to current and future challenges. Crit Rev Toxicol, 2013; 43:1–20.
13.
ShatkinJA, OngKJ. Alternative testing strategies for nanomaterials: State of the science and considerations for risk analysis. Risk Anal, 2016; 36:1564–1580.
14.
YuanD, HeH, WuY, et al.Physiologically based pharmacokinetic modeling of nanoparticles. J Pharm Sci, 2019; 108:58–72.
15.
AlsalehNB, BrownJM. Immune responses to engineered nanomaterials: Current understanding and challenges. Curr Opin Toxicol, 2018; 10:8–14.
16.
RiedikerM, ZinkD, KreylingW, et al.Particle toxicology and health—Where are we?. Part Fibre Toxicol, 2019:16:19.
17.
LoretT, RogerieuxF, TrouillerB, et al.Predicting the in vivo pulmonary toxicity induced by acute exposure to poorly soluble nanomaterials by using advanced in vitro methods. Part Fibre Toxicol, 2018; 15:25.
18.
ChenR, QiaoJ, BaiR, et al.Intelligent testing strategy and analytical techniques for the safety assessment of nanomaterials. Anal Bioanal Chem, 2018; 410:6051–6066.
19.
ClippingerAJ, AhluwaliaA, AllenD, et al.Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials. Arch Toxicol, 2016; 90:1769–1783.
20.
PezzuloAA, StarnerTD, ScheetzTE, et al.The air–liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol, 2011; 300:L25–31.
21.
JohnstonHJ, VerdonR, GilliesS, et al.Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials. Crit Rev Toxicol, 2018:48:252–271.
22.
LinS, MortimerM, ChenR, et al.NanoEHS beyond toxicity—Focusing on biocorona. Environ Sci Nano, 2017; 4:1433–1454.
23.
LuanpitpongS, WangL, MankeA, et al.Induction of stemlike cells with fibrogenic properties by carbon nanotubes and its role in fibrogenesis. Nano Lett, 2014; 14:3110–3116.
24.
HofmannMC. Stem cells and nanomaterials. Adv Exp Med Biol, 2014; 811:255–275.
25.
SumaRN, MohananPV. Stem cells, a new generation model for predictive nano toxicological assessment. Curr Drug Metab, 2015; 16:932–939.
26.
ShakeelM, JabeenF, ShabbirS, et al.Toxicity of nano-titanium dioxide (TiO2-NP) through various routes of exposure: A review. Biol Trace Elem Res, 2016; 172:1–36.
